Announcements Trials
Browse Landscape

Phase

Phase 3 4Phase 2 2

Status

Recruiting 11Active not recruiting 7Completed 4Not yet recruiting 2Enrolling by invitation 1

Sponsor Class

OTHER 6OTHER_GOV 1

Study Type

Interventional 6Observational 1

Sponsor

Cancer Type

Gynecologic 4Gastrointestinal 3

Conditions

Stomach Neoplasms 2Ovarian Neoplasms 2Peritoneal Neoplasms 1Ovarian Epithelial Cancer Recurrent 1Neoplasm Metastasis 1HIPEC 1Colorectal Neoplasms 1Carcinoma, Ovarian Epithelial 1Appendiceal Neoplasms 1

Interventions

pembrolizumab 374Carboplatin 276Specimen Handling 265Nivolumab 252Magnetic Resonance Spectroscopy 244Cyclophosphamide 240Cisplatin 213Paclitaxel 206Radiotherapy 195Biopsy 171Gemcitabine 155Dexamethasone 148durvalumab 143atezolizumab 126Rituximab 120Doxorubicin 115Bevacizumab 114Lenalidomide 113Ipilimumab 111Radiation 109Docetaxel 103Pemetrexed 102Etoposide 101fludarabine 97venetoclax 95Fluorouracil 92Capecitabine 92Radiosurgery 90Prednisone 89Oxaliplatin 89

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
Active not recruiting × Hyperthermic Intraperitoneal Chemotherapy × 1 year × Clear all
NCT01376752 2026-05-20

CHIPOR

UNICANCER

Phase 3 Active not recruiting
415 enrolled
Gynecologic

Ovarian Epithelial Cancer Recurrent

NCT03842982 2026-03-16

CHIPPI

Centre Oscar Lambret

Phase 3 Active not recruiting
362 enrolled
Gynecologic

Ovarian Neoplasms

NCT05316181 2026-02-12

KOV-HIPEC-02R

National Cancer Center, Korea

Phase 3 Active not recruiting
140 enrolled
Gynecologic

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms

NCT01815359 2026-02-05

ICARuS

Memorial Sloan Kettering Cancer Center

Phase 2 Active not recruiting
292 enrolled
Gastrointestinal

Appendiceal Neoplasms, Colorectal Neoplasms

NCT07353177 2026-01-20

Effects of HIPEC on Postoperative Bowel Motility and Complications

Peking University People's Hospital

Active not recruiting
193 enrolled

HIPEC

NCT03348150 2025-07-17

PERISCOPEII

The Netherlands Cancer Institute

Phase 3 Active not recruiting
102 enrolled
GastrointestinalGynecologic

Peritoneal Neoplasms, Stomach Neoplasms

NCT06427252 2025-07-16

The Efficacy and Safety of HIPEC Combined With PD-1 and SOX Chemotherapy for the Translational Treatment of GC or EGJC With PM

The First Affiliated Hospital with Nanjing Medical University

Phase 2 Active not recruiting
50 enrolled
Gastrointestinal

Neoplasm Metastasis, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡